Montelukast Sodium
NDC 59651-329, Montelukast Sodium, granule, from Aurobindo Pharma Limited.
- Product NDC
- 59651-329
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213471
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-329 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MONTELUKAST SODIUM4 mg/1
Pharmacologic classes
Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-329-30 | 59651032930 | 30 PACKET in 1 CARTON (59651-329-30) / 1 GRANULE in 1 PACKET (59651-329-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9a3bfc59-0ca6-4433-abf5-41659bfe0a8fNADAC price for package 59651032930
GET /v1/drugs/nadac/59651032930
Use it
Look up 59651-329 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-329 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-329. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.